GH

Guardant Health Inc
$159.32+$0.53+0.33%Price as of Nov 10, 2026, 9:53 AM ET

Key stats

Market cap
21.4B
Open
—
Day range
—
52-week range
$74.55 – $191.05
Volume
303K
Avg volume
2.10M

Earnings

Q3 FY26Beat
Expected$-0.33
Actual$-0.29
Q2 FY26
Actual$-0.90
Q1 FY26
Actual$-0.85
Q4 FY25
Actual$-1.00

Next earnings call Feb 18, 2027

About

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Employees
2,506
Headquarters
Palo Alto, CA